ShuYu Civilian Pharmacy Corp. Ltd.

Shuyu Pingmin released its 2026 interim report. Total operating revenue was 5.314 billion yuan, and net profit attributable to the parent company was 25.776 million yuan, down 28.90% from the same period last year. Net cash inflow from operating activities was 43.701 million yuan, down 68.30% year-on-year. The company's asset-liability ratio was 76.80%, gross margin was 26.44%, ROE was 1.23%, and diluted earnings per share was 0.06 yuan. The number of shareholders was 16,500, and the shareholding ratio of the top ten shareholders was 74.76%.

Shuyu Pingmin controlling shareholder Li Wenjie has pledged 9.62 million shares, representing 7.15% of his holdings and 2.37% of the company's total share capital. As of the announcement date, Li Wenjie and his concert parties have cumulatively pledged 62.48 million shares, accounting for 29.59% of their holdings and 15.40% of the company's total share capital. In the first quarter of 2026, Shuyu Pingmin achieved revenue of 2.601 billion yuan and net profit attributable to the parent company of 10.36 million yuan.

Shuyu Pingmin announced that its wholly-owned subsidiary, Liaoning Shuyu Pingmin Enterprise Management Co., Ltd., has received 1.96 million yuan in performance commitment compensation from the relevant performance commitment party of Liaoning Shuyu Pingmin Yiming Pharmacy Chain Co., Ltd. During the performance commitment period, Liaoning Yiming achieved a total revenue completion rate of 101.39%, but its total net profit completion rate was only 84.91%, failing to meet the performance commitment, thus the relevant party was required to fulfill the compensation obligation. In the first quarter of 2026, Shuyu Pingmin achieved revenue of 2.601 billion yuan and net profit attributable to the parent company of 10.36 million yuan.